Consider validity, clinical relevance, and applicability of albumin for critically ill patients

BMJ 1998; 317 doi: 10.1136/bmj.317.7154.343 (Published 1 August 1998)
Cite this as: BMJ 1998;317:343.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Martin Offringa, Consultant neonatologist
  1. Emma Children's Hospital, Academic Medical Centre, 1105 AZ Amsterdam, Netherlands

    EDITOR—Because of a series of questions I have received about the current clinical use of human albumin in critically ill patients, I wish to clarify the message that I intended my editorial last week to convey.1

    Given the current evidence as summarised by the Cochrane albumin reviewers group,).2 the …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL